drugset
drugset / Trial / NCT03361540

ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Subjects

NCT03361540 ↗

Phase 1 Completed 56 enrolled Astellas Pharma Inc
RandomizedSequentialTriple-blindBasic science

Summary

The objective of this study is to evaluate the safety, tolerability and pharmacokinetic of single/multiple ascending oral doses of ASP8302 in non-elderly healthy Japanese male and female subjects.

Timeline

Start
2017-11-14
Primary completion
2018-04-30
Completion
2018-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject ASP8302 Small molecule — Oral

Indications

No indication recorded.